- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/42 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
Patent holdings for IPC class C07C 235/42
Total number of patents in this class: 113
10-year publication summary
8
|
11
|
7
|
8
|
12
|
5
|
9
|
9
|
3
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Neurocrine Biosciences, Inc. | 399 |
5 |
The Salk Institute for Biological Studies | 446 |
5 |
BASF SE | 20777 |
4 |
Eli Lilly and Company | 3814 |
4 |
Ajinomoto Co., Inc. | 2298 |
3 |
Mitobridge, Inc. | 35 |
3 |
Plastipak Packaging, Inc. | 316 |
3 |
Novartis AG | 10904 |
2 |
Samsung Electronics Co., Ltd. | 144143 |
2 |
F. Hoffmann-La Roche AG | 7926 |
2 |
The Regents of the University of California | 19812 |
2 |
Dow AgroSciences LLC | 1225 |
2 |
The Trustees of Columbia University in the City of New York | 3558 |
2 |
ChemoCentryx, Inc. | 389 |
2 |
Oregon Health & Science University | 762 |
2 |
Techfields Biochem Co. Ltd | 17 |
2 |
University of Kansas | 867 |
2 |
Venantius Limited | 4 |
2 |
UK Chemipharm Co., Ltd. | 6 |
2 |
Biomea Fusion, LLC | 3 |
2 |
Other owners | 60 |